By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Apotex Inc. 

150 Signet Drive

Toronto  Ontario  M9L 1T9  Canada
Phone: 416-749-9300 or 800-268-4623 Fax: 416-401-3835




Company News
Apotex Launches First Generic Version Of Merck & Co. (MRK)'s Nasonex 3/22/2016 7:30:24 AM
Shakeup at Canada's Largest Pharma Firm Apotex 3/17/2015 6:00:37 AM
Apotex Inc. Announces FDA Has Accepted For Filing its Biosimilar Application for Filgrastim (Grastofil) 2/18/2015 7:41:59 AM
Apotex Inc. Announces FDA Has Accepted For Filing Its Biosimilar Application For Pegfilgrastim 12/17/2014 9:16:55 AM
Apotex Inc. Sues Health Canada Over An ‘Unlawful’ Ban On Its Drugs 11/24/2014 6:14:16 AM
Apotex Inc. Release: Setting The Record Straight: Products Are Safe And Effective 9/26/2014 9:53:34 AM
Information Update - Health Canada Requests Quarantine Of Products For Canadian Market From Apotex Inc. Facility In Bangalore, India 9/25/2014 7:48:02 AM
Apotex Inc. Release: Medicine To Treat 1 In 10 Haitians Arrives In Port-au-Prince 9/11/2014 8:13:11 AM
Appointment Announcement - Dr. Jeremy B. Desai, President and CEO, Apotex Inc. 8/27/2014 7:22:06 AM
Apotex Inc. Release: NAFTA Tribunal Decision Supports FDA And Its Actions 8/26/2014 9:29:10 AM